Mark joined in KPMG China in 2008 where he advises clients on investments in China including due diligence, joint ventures, vendor assistance, SPA drafting and completion accounts. Mark has extensive transaction service experiences in pharmaceutical & healthcare, consumer markets, industrial markets in China, granting his in-depth knowledge of sector characteristics and client’s primary concerns.